Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Clin Exp Pharmacol Physiol ; 31(1-2): 107-9, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-14756693

RESUMO

1. We established a new animal model of metabolic syndrome, SHRSP fatty (fa/fa) rats, by crossing stroke-prone spontaneously hypertensive rats of the Izumo strain (SHRSP/Izm) to Zucker fatty (ZF) (fa/fa) rats. 2. The SHRSP fatty (fa/fa) rats have a missense mutation of the leptin receptor gene and plasma leptin concentrations are augmented. The SHRSP fatty (fa/fa) rats develop obesity and hypertension simultaneously. 3. Plasma metabolic parameters, including glucose, insulin and total cholesterol and triglyceride levels, were markedly elevated in SHRSP fatty (fa/fa) rats compared with SHRSP/Izm rats. Plasma triglyceride concentrations in SHRSP fatty (fa/fa) rats were significantly elevated compared with those in ZF (fa/fa) rats. The weight of adipose tissues in SHRSP fatty (fa/fa) rats was greater than that of SHRSP/Izm rats. The phenotype of SHRSP fatty (fa/fa) rats is similar to that of human metabolic syndrome.


Assuntos
Síndrome Metabólica/fisiopatologia , Tecido Adiposo/anatomia & histologia , Animais , Glicemia/metabolismo , Composição Corporal/fisiologia , Peso Corporal/fisiologia , Doenças Cardiovasculares/etiologia , Doenças Cardiovasculares/genética , Modelos Animais de Doenças , Hemodinâmica/genética , Hemodinâmica/fisiologia , Insulina/sangue , Lipídeos/sangue , Síndrome Metabólica/genética , Mutação/fisiologia , Obesidade/genética , Fenótipo , Ratos , Ratos Endogâmicos SHR , Ratos Zucker , Receptores de Superfície Celular/genética , Receptores para Leptina
2.
Clin Exp Pharmacol Physiol ; 31 Suppl 2: S37-8, 2004 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-15649284

RESUMO

1. Recent studies have identified potential beneficial effects of eating nuts, most of which have substantial amounts of monounsaturated fatty acids (MUFA). Macadamia nuts consist of 75% fat by weight, 80% of which is MUFA (palmitoleic acid). 2. To examine variations in serum lipid levels in response to a high-MUFA diet based on macadamia nuts, 3 week interventions of macadamia nuts, coconuts and butter were determined in young, healthy Japanese female students. 3. After 3 weeks intervention, serum concentrations of total cholesterol and low-density lipoprotein-cholesterol were significantly decreased in the macadamia nut and coconut diets and bodyweight and body mass index were decreased in the group fed macadamia nuts, although there were no statistically significant changes in the group fed butter.


Assuntos
Gorduras Insaturadas na Dieta/administração & dosagem , Ácidos Graxos Monoinsaturados/administração & dosagem , Lipídeos/sangue , Macadamia , Adulto , Povo Asiático , Índice de Massa Corporal , Peso Corporal/efeitos dos fármacos , Pão , Manteiga , Cocos , Dieta , Feminino , Humanos
3.
Thromb Res ; 106(2): 165-8, 2002 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-12182917

RESUMO

We have previously established an animal model to investigate mechanisms of arterial thrombolysis in vivo and have demonstrated that endogenous thrombolysis, mediated by thrombin-activatable fibrinolysis inhibitor, is enhanced by administration of specific thrombin inhibitors. The aim of the present study was to evaluate the effects of a synthetic and specific factor Xa inhibitor, DX-9065a, on endogenous fibrinolysis. Mural thrombi were formed in rat mesenteric arterioles by helium-neon laser irradiation in the presence of Evans blue. Thrombolysis was continuously monitored by video microscopy and was quantified using image analysis software. Oral and intravenous administration of DX-9065a enhanced endogenous thrombolysis in vivo. The mechanisms require additional investigation using other experimental systems, but nevertheless, the present results extended our previous findings and further suggested that the enhanced fibrinolysis might be due to depressed activity thrombin-activatable fibrinolysis inhibitor. The synthetic factor Xa inhibitor could provide the basis for a useful thrombolytic agent.


Assuntos
Inibidores Enzimáticos/uso terapêutico , Inibidores do Fator Xa , Fibrinolíticos/uso terapêutico , Oclusão Vascular Mesentérica/tratamento farmacológico , Naftalenos/uso terapêutico , Propionatos/uso terapêutico , Terapia Trombolítica , Trombose/tratamento farmacológico , Administração Oral , Animais , Arteríolas , Avaliação Pré-Clínica de Medicamentos , Inibidores Enzimáticos/administração & dosagem , Inibidores Enzimáticos/farmacologia , Fibrinólise/efeitos dos fármacos , Fibrinolíticos/administração & dosagem , Fibrinolíticos/farmacologia , Processamento de Imagem Assistida por Computador , Infusões Intravenosas , Masculino , Microscopia de Vídeo , Naftalenos/administração & dosagem , Naftalenos/farmacologia , Propionatos/administração & dosagem , Propionatos/farmacologia , Ratos , Ratos Wistar , Reprodutibilidade dos Testes
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...